Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Alector Grants Genentech Worldwide Rights to AL050 in $1.27B Deal – Brain‑Penetrant GCase Therapy Targets Neurodegeneration in Parkinson's Disease
CompanyDeals

Alector Grants Genentech Worldwide Rights to AL050 in $1.27B Deal – Brain‑Penetrant GCase Therapy Targets Neurodegeneration in Parkinson’s Disease

Alector, Inc. (NASDAQ: ALEC) announced an exclusive global licensing agreement with Genentech, a member of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), granting Genentech worldwide rights to develop and commercialize…

CSL Behring and Alentis Therapeutics Forge $1.55B Global Lixudebart Alliance – Anti‑Claudin‑1 Antibody Targets Rare Autoimmune Kidney, Liver, and Lung Diseases

CSL Behring and Alentis Therapeutics Forge $1.55B Global Lixudebart Alliance – Anti‑Claudin‑1 Antibody Targets Rare Autoimmune Kidney, Liver, and Lung Diseases

BGM0504 Delivers Up to 19.2% Weight Loss in Phase III at EASD 2026 – CR Sanjiu and BrightGene's GLP‑1/GIP Dual Agonist Meets All Endpoints in Chinese Population

BGM0504 Delivers Up to 19.2% Weight Loss in Phase III at EASD 2026 – CR Sanjiu and BrightGene’s GLP‑1/GIP Dual Agonist Meets All Endpoints in Chinese Population

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Betta Pharmaceuticals' MCLA-129 Approved for Clinical Trial in Advanced Solid Tumors
CompanyDrug

Betta Pharmaceuticals’ MCLA-129 Approved for Clinical Trial in Advanced Solid Tumors

Xeltis AG Enrolls First Patient in US Pivotal Trial for aXess with FDA BTD Status
CompanyMedical Device

Xeltis AG Enrolls First Patient in US Pivotal Trial for aXess with FDA BTD Status

Huadong Medicine's DR10624 Receives NMPA Approval for MAFLD and MASH Clinical Trials
CompanyDrug

Huadong Medicine’s DR10624 Receives NMPA Approval for MAFLD and MASH Clinical Trials

Huadong Medicine's HDM1005 Receives FDA Approval for MASH Clinical Study
CompanyDrug

Huadong Medicine’s HDM1005 Receives FDA Approval for MASH Clinical Study

Beijing Wantai Receives NMPA Clearance for Nine-Valent HPV Vaccine Targeting Male Population
CompanyDrug

Beijing Wantai Receives NMPA Clearance for Nine-Valent HPV Vaccine Targeting Male Population

Hasten Biopharmaceutical Initiates Phase III Clinical Trial for Lerodalcibep in China
CompanyDrug

Hasten Biopharmaceutical Initiates Phase III Clinical Trial for Lerodalcibep in China

CanSino Biologics Initiates Phase I Clinical Trial for Freeze-Dried Hib Conjugate Vaccine
CompanyDrug

CanSino Biologics Initiates Phase I Clinical Trial for Freeze-Dried Hib Conjugate Vaccine

Sichuan Kelun-Biotech Secures NMPA Approval for Two Antibody Drug Conjugates
CompanyDrug

Sichuan Kelun-Biotech Secures NMPA Approval for Two Antibody Drug Conjugates

Show More